Neurocrine Biosciences NBIX
NASDAQ NBIX
$154.39 -0.74 (-0.48%)
As of: Sep 9, 2026 · 3:06 PM EDT

Neurocrine Biosciences (NBIX) Exchange Rate Effect (2023 - 2025)

Neurocrine Biosciences' (NBIX) quarterly Exchange Rate Effect came in at -$200000.0 in Q3 2025, down 166.67% on a YoY basis from $300000.0 in Q3 2024, and up 33.33% quarter-over-quarter from -$300000.0 in Q4 2024.

Analysis

Neurocrine Biosciences (NBIX) Exchange Rate Effect (2023 - 2025) Analysis & Trends

Neurocrine Biosciences (NBIX) has reported Exchange Rate Effect for 3 consecutive years, with -$200000.0 the latest figure, recorded in Q3 2025.

  • For the quarter ending Q3 2025, Exchange Rate Effect fell 166.67% year-over-year to -$200000.0; the trailing twelve-month figure through Dec 2025 stood at -$200000.0 (changed N/A YoY), and the FY2023 full-year result was $300000.0, up 123.08% from the prior year.
  • Exchange Rate Effect advanced to -$200000.0 in Q3 2025 per NBIX's latest filing, from -$300000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $300000.0 in Q4 2023 and bottomed at -$300000.0 in Q4 2024.
  • Historically, Exchange Rate Effect has averaged $25000.0 across 3 years, with a median of $50000.0 in 2023.
  • The sharpest annual moves came in 2024 and 2025: Exchange Rate Effect slumped 200.0% in 2024, then sank 166.67% in 2025.
  • Over 3 years, Exchange Rate Effect stood at $300000.0 in 2023, then plunged by 200.0% to -$300000.0 in 2024, then soared by 33.33% to -$200000.0 in 2025.
  • According to Business Quant data, Exchange Rate Effect over the past three periods registered -$200000.0, -$300000.0, and $300000.0 for Q3 2025, Q4 2024, and Q3 2024 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Exchange Rate Effect (Qtr)
1 Johnson & Johnson 646.13 Bn 625.38 Bn 17.26 Bn 5.00 Mn
2 AbbVie 442.39 Bn 435.82 Bn 12.70 Bn -7.00 Mn
3 Merck 366.26 Bn 359.12 Bn 12.21 Bn -37.00 Mn
4 Novartis Ag 266.58 Bn 258.89 Bn 11.24 Bn -18.00 Mn
5 Pfizer 159.00 Bn 147.30 Bn 10.94 Bn -4.00 Mn
6 Sanofi 52.39 Bn 45.00 Bn 10.79 Bn 11.62 Mn
7 Revolution Medicines 43.98 Bn 43.98 Bn - -
8 Incyte 25.41 Bn 20.87 Bn 1.57 Bn -84,000.00
9 United Therapeutics 21.54 Bn 18.88 Bn 683.80 Mn -
10 Neurocrine Biosciences 15.59 Bn 15.20 Bn 935.80 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -200,000.00
Dec 31, 2024 -300,000.00
Sep 30, 2024 300,000.00
Dec 31, 2023 300,000.00